News

Billion-dollar Hong Kong IPOs keep coming as China’s biggest drug company joins rush
Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.
The Manila Times5h
NYSE American Delisting Action Has No Effect on the Trading of the Ordinary Shares on the Stock Exchange of Hong Kong
Graphex Group Limited ("Graphex Group” or the "Company”) (HKSE: 6128)) announced today that the NYSE American LLC (the "New ...
Singapore biotech start-up Mirxes launches IPO in Hong Kong to raise $181 million
Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.
CATL Targets Global Energy Market Rules with Hong Kong IPO Push
As trade restrictions tighten across the U.S. and EU, and as global technology rivalries deepen, CATL's ambitions stretch ...
Yahoo Finance9d
Hong Kong Exchanges and Clearing Limited (HKXCF)
Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to welcome today (Monday) the listing of Asia's first Single Stock Leveraged and Inverse Products (L&I Products) in Hong Kong ...
China's CATL to raise $4 billion in Hong Kong listing
(Reuters) -Chinese battery manufacturer CATL aims to raise about HK$31.01 billion ($3.99 billion) in its Hong Kong listing, ...
The threat to kick China out of U.S. exchanges is growing, and Hong Kong stands to benefit
Delisting worries have grown since late February, when President Donald Trump revived the threat of kicking Chinese companies ...